Invention Grant
- Patent Title: Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
-
Application No.: US16074357Application Date: 2017-01-31
-
Publication No.: US11357777B2Publication Date: 2022-06-14
- Inventor: G-Yoon Jamie Im , Mark G. Currie , James Edward Sheppeck , Paul Allan Renhowe , Pei Ge , Jaime L. Masferrer
- Applicant: Cyclerion Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Cyclerion Therapeutics, Inc.
- Current Assignee: Cyclerion Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Xin Zhang
- International Application: PCT/US2017/015749 WO 20170131
- International Announcement: WO2017/136309 WO 20170810
- Main IPC: A61K31/505
- IPC: A61K31/505 ; A61P1/16 ; A61K31/506 ; A61K31/197 ; A61K31/198 ; A61K31/5377 ; A61K31/575 ; A61K33/00 ; A61K35/20 ; A61K39/395 ; A61K45/06 ; A61K31/4985 ; A61K31/519 ; A61K31/53 ; A61K31/541
Abstract:
The present disclosure relates to methods, uses, pharmaceutical compositions and kits comprising an sGC stimulator or a pharmaceutically acceptable salt thereof, alone or in combination with one or more additional therapeutic agents, for the treatment of Nonalcoholic Steatohepatitis (NASH).
Public/Granted literature
- US20210161893A1 USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH) Public/Granted day:2021-06-03
Information query
